Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02397720. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
ClinicalTrials.gov study NCT02993523. IPD Sharing: YES. Countries: 29. Publications: 9.
Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans
ClinicalTrials.gov study NCT00541866. IPD Sharing: NO. Countries: 1. Publications: 1.
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00840177. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT02588092. IPD Sharing: NO. Countries: 1. Publications: 1.
Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00492401. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02642965. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Trial of Decitabine in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00260832. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Sy
ClinicalTrials.gov study NCT01835587. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03071276. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
ClinicalTrials.gov study NCT03182244. IPD Sharing: YES. Countries: 5. Publications: 1.
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05748197. IPD Sharing: YES. Countries: 1. Publications: 1.
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02152956. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02545283. IPD Sharing: Not stated. Countries: 19. Publications: 1.
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01707004. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
ClinicalTrials.gov study NCT02484391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06017258. IPD Sharing: YES. Countries: 1. Publications: 1.
Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
ClinicalTrials.gov study NCT04874194. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02530476. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
ClinicalTrials.gov study NCT01025154. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.